Doc DateTitleFile Typedoc_year_hfilter
10/28/2019CardieX 2019 Annual Report2019
08/20/2019AtCor Senior Management Changes2019
12/22/2017Becoming a substantial holder2017
12/21/2017Initial directors interest notice2017
12/21/2017Final directors interest notice2017
12/20/2017Appointment of Niall Cairns2017
12/15/2017AtCor Medical secures new $1m pharmaceutical contract2017
12/05/2017Initial directors interest notice2017
12/05/2017Final directors interest notice2017
11/30/2017Results of meeting2017
11/30/2017Chairman’s address2017
11/30/2017AtCor Medical appoints Craig Cooper as CEO2017
11/15/2017Craig Cooper to join AtCor Medical Board2017
10/30/2017Tax refund2017
10/27/2017Notice of annual general meeting2017
10/27/2017Appendix 4G corporate governance2017
09/29/2017Change of directors interest notice2017
09/22/2017Completion of share purchase plan2017
09/22/2017Appendix 3B2017
09/14/2017Viking Yacht adds SphygmoCor for employee wellness2017
09/05/2017Security purchase plan2017
08/31/2017Full year statutory accounts2017
08/29/2017Share purchase plan2017
08/16/2017Cleansing notice2017
08/15/2017Appendix 3B2017
08/08/2017Share placement2017
08/04/2017Trading halt2017
08/02/2017AtCor Medical Restructures Operations2017
07/31/2017AtCor Medical signs new agreement2017
07/12/2017AtCor Medical secures $0.8 million in new pharmaceutical contract2017
06/07/2017AtCor Medical signs new network health system agreement2017
05/18/2017Business update and strategic review2017
02/24/2017Half yearly reports and accounts2017
02/23/2017AtCor Medical signs local health system agreement2017
02/16/2017Study on central aortic waveform in heart failure2017
02/14/2017Tax refund2017
01/25/2017Central blood pressure and cognitive decline2017
01/23/2017Positive Novartis drug trial using SphygmoCor2017
08/31/2018CardieX appendix 4E and 2018 annual financial statements2018
08/29/2018Becoming a substantial holder2018
08/28/2018Appendix 3B2018
07/24/2018CardieX reports successful trial results for wearable sensor2018
07/04/2018Form 604 – change in substantial holding2018
07/03/2018CardieX restructure and new executive appointments2018
06/19/2018CardieX makes first investment in wearable tech partnership2018
06/18/2018CardieX commences trading under new code ASX_CDX2018
06/15/2018Appendix 3B2018
06/12/2018CardieX (AtCor Medical) entitlements issue heavily over subscribed2018
06/05/2018Appendix 3Y – O’Dwyer2018
06/05/2018Appendix 3B2018
06/01/2018Appendix 3Y – Cooper2018
06/01/2018Appendix 3Y – Cairns2018
06/01/2018Appendix 3B2018
05/31/2018Revised timing on trade commencement2018
05/30/2018Change of name to CardieX Limited2018
05/28/2018Results of EGM2018
05/03/2018Despatch of underwritten rights issue prospectus2018
05/01/2018Completion of placement and notice under s708A2018
05/01/2018Appendix 3B – completion of placement2018
04/30/2018Notice of EGM and proxy despatched2018
04/26/2018Letter to ineligible shareholders2018
04/26/2018Letter to eligible shareholders2018
04/24/2018Appendix 3B – entitlements issue2018
04/23/2018Underwritten rights issue prospectus lodged with ASIC2018
04/23/2018Over subscribed capital raising to fast track strategy2018
04/19/2018Trading halt2018
04/05/2018Final directors interest notice – D Brookes2018
04/03/2018Change to board of directors2018
03/14/2018AtCor Medical announces first step in major strategic repositioning2018
03/06/2018Resignation of CFO and company secretary2018
02/28/2018Half yearly report and accounts2018
01/23/2018AtCor Medicals’ XCEL device clinically validated in third party study2018
01/18/2018AtCor Medical and PhysioAge Systems announce supply agreement2018
06/05/2019CDX Achieves Major Milestone in Wearable Sensor Development2019
12/06/2018CardieX Successfully Closes Oversubscribed $5.5m Fundraising2018
12/12/2018CardieX Signs Agreement for Wearable Sensor Development2018
12/14/2018Appendix 3B2018
12/18/2018CardieX’s inHealth Signs LOI With Global Electronics Company2018
12/19/2018Cleansing Notice Under s708A(5)(e)2018
12/19/2018Notice Under ASX Listing Rule 3.10.5A2018
01/11/2019Top 20 Shareholders2019
01/14/2019Top 20 and Capital Structure2019
01/15/2019Cardiex’s inHealth Executes Major Co-Marketing Agreement2019
01/18/2019Response to ASX Aware Query2019
01/22/2019Convertible Note Application Received from C2 Ventures2019
01/25/2019Notice of Extraordinary General Meeting/Proxy Form2019
01/25/2019CardieX Despatches Notice of EGM to Shareholders2019
01/30/2019CardieX Progress Summary & CEO Outlook2019
02/01/2019CardieX Update on the Acquisition of 50.5% of inHealth2019
02/04/2019Transition of Chairman Role2019
02/04/2019CardieX Technology Validated in Chinese Clinical Study2019
02/21/2019Achievement of First CEO Performance Rights Hurdle2019
02/26/2019Senior Health Executive Appointed to Cardiex Advisory Board2019
02/26/2019Results of Extraordinary General Meeting2019
02/27/2019Final Director’s Interest Notice2019
02/27/2019Transition of Directors & New Interim Chairman Appointment2019
02/28/2019Half Year Accounts2019
02/28/2019Appendix 4D Half Year Report2019
03/06/2019CardieX Announces Expansion of Bayer Pharma Trial Contract2019
03/06/2019Appendix 3B2019
03/12/2019CardieX China and Product Strategy Update – English2019
04/01/2019CardieX Corporate Update and Report from CEO2019
04/02/2019CardieX and inHealth Collaboration in Landmark US Study2019
04/16/2019Appendix 3B2019
04/23/2019Oscar 2 Medical Device Receives China FDA Approval2019
05/20/2019CDX & inHealth Sign MOU with Major Chinese Telemed Company2019
05/21/2019CardieX Establishes Local Operations in China2019
05/22/2019s604 and Change in Director’s Interest Notices2019
05/24/2019CDX & Blumio Present Successful Trial Results at IEEE2019
05/28/2019inHealth Delivers on Rapid Growth Expectations2019
06/04/2019Wearables & Blumio Update from CEO of CardieX2019
05/29/2019Senior Healthcare Executive Rhonda Welch Appointed Vice President of Global Marketing2019
05/20/2019CardieX and inHealth Collaborate on Pilot Program with Leading Chinese Telemedicine Platform Health160 to Deploy inHealth Solutions Across China2019
05/21/2018AtCor Medical announces wearable trial with Macquarie University2018
05/21/2018Blumio wearable cardio trial with Macquarie University2018